Source: Annual Congress 2009 - COPD: exacerbation and clinical problems
Disease area: Airway diseases, Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
T. Pertseva, L. Konopkina (Dnipropetrovsk, Ukraine). Lower respiratory tract infection (LRTI): are there differences of microbial spectrum in stable phase (SP) of COPD and during acute exacerbation (AE)?. Eur Respir J 2009; 34: Suppl. 53, 3472

Member's Comments

No comment yet.

Related content which might interest you: Mucociliary clearance (MCC) disorders in patient with acute bronchitis (AB) and acute exacerbation (AE) of COPD and ways of it correction Source: Annual Congress 2009 - Drug effects in COPD Year: 2009 Management of lower respiratory tract infections by French general practitioners: the AIR II study Source: Eur Respir J 2002; 19: 314-319 Year: 2002 Low respiratory tract infection (LRTI) in ALS patients. A regional referring centre experience Source: International Congress 2018 – Difficult-to-treat respiratory infections Year: 2018 The estimation of respiratory muscles (RM) status by echodensitometry in male patients with acute exacerbation of COPD (AECOPD) Source: Annual Congress 2010 - Interaction between respiratory and peripheral muscles Year: 2010 Association of asthma exacerbations and upper respiratory tract infections (URTIs) Source: Annual Congress 2009 - Clinical aspects of inflammatory airways diseases Year: 2009 Influence of recent acute respiratory tract infections (ARTI) on lung function testing in healthy and asthmatic children (LUNOKID Study) Source: Annual Congress 2010 - Lung function from infancy to adulthood Year: 2010 Time-course of upper respiratory tract viral infection and COPD exacerbation Source: Eur Respir J, 54 (4) 1900407; 10.1183/13993003.00407-2019 Year: 2019 Seasonal distribution of acute respiratory tract infections (RTIs) due to respiratory syncytial virus (RSV), to Mycoplasma pneumonia (MP) and to Chlamydia pneumonia (CP) Source: Eur Respir J 2001; 18: Suppl. 33, 234s Year: 2001 Acute respiratory failure (ARF) and severe sepsis (SS) in community acquired pneumonia (CAP): different outcomes? Source: Annual Congress 2009 - Impact of biomarkers in the management of community-acquired pneumonia Year: 2009 Viral upper respiratory infection and acute asthma exacerbation Source: Annual Congress 2009 - Viruses and respiratory infections: prevalence and mechanisms of infection Year: 2009 Aetiology of lower respiratory tract infection (LRTI) in primary care Source: Annual Congress 2004 - Community acquired pneumonia - epidemiology and host defence Year: 2004 Prospective study on the contribution of respiratory syncytial virus (RSV) to acute lower respiratory tract infections (ALRTI) in young hospitalised children Source: Eur Respir J 2004; 24: Suppl. 48, 622s Year: 2004 The role of infections in acute exacerbations of COPD Source: Annual Congress 2005 - Infection and acute exacerbation of COPD: what do we know? Year: 2005 Serum procalcitonin (PCT-Q) as a diagnostic tool for bacterial lower respiratory tract infection among COPD patients with acute exacerbation Source: Annual Congress 2013 –Difficult and rare respiratory infections Year: 2013 The difference between surfactant protein D (SPD) and C-reactive protein (CRP) levels in patients (pts) with chronic obstructive pulmonary disease acute exacerbations (AE COPD) and community acquired pneumonia (CAP) Source: International Congress 2014 – Clinical presentations Year: 2014 State of immunity at children with a bronchial asthma (BA) and acute respiratory virus infection (ARVI) Source: Eur Respir J 2007; 30: Suppl. 51, 644s Year: 2007 Eosinopenia in COPD patients with severe acute respiratory virus 2 (Sars-CoV-2) infection as a potential fatal outcome predictor Source: Virtual Congress 2021 – COVID-19 and obstructive diseases: risk factors, management and long-term effects Year: 2021 Chlamydia pneumonia (CP), Mycoplasma pneumonia (MP) and virus antibody titres in acute exacerbations of asthma (BA) and chronic bronchitis (COPD) Source: Eur Respir J 2001; 18: Suppl. 33, 234s Year: 2001 Treatment of community-acquired lower respiratory tract infections in adults Source: Eur Respir J 2002; 20: 40S-53S Year: 2002 Surfactant protein D (SPD) and C-reactive protein (CRP) in patient with low respiratory tract infections (LRTI) Source: Annual Congress 2013 –Lung infections: a clinical point of view Year: 2013